Prof. Dana Wolf, M.D., to Present at CMV2017: 6th International Congenital CMV Conference and 16th International CMV/Betaherpesvirus Workshop

Artemis Therapeutics’ Chief Scientific Officer to participate in Virus and Host Session on Tuesday, May 2, 2017 at 3:15 PM CEST

NEW YORK, NY–(Marketwired – April 27, 2017) – Artemis Therapeutics, Inc. (OTC PINK: ATMS), (“Artemis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of agents for the prevention and treatment of severe and potentially life-threatening infectious diseases, is pleased to announce that Prof. Dana Wolf, M.D., Ted and Frances Chanock Professor of Virology and Head of Clinical Virology at Hadassah Hebrew University Medical Center, and Chief Scientific Officer of Artemis Therapeutics, is an invited speaker at CMV2017: 6th Annual International Congenital CMV Conference and 16th International CMV / Betaherpesvirus Workshop being held April 30-May 4, 2017 at the NH Conference Centre Leeuwenhorst in Noordwijkerhout, Netherlands.

Click to view entire Press Release